Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
2.290
-0.070 (-2.97%)
At close: Dec 5, 2025, 4:00 PM EST
2.313
+0.023 (0.99%)
After-hours: Dec 5, 2025, 5:46 PM EST
Traws Pharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Traws Pharma stock has a target of 8.00, which predicts a 249.34% increase from the current stock price of 2.29.
Price Target: $8.00 (+249.34%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Traws Pharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 |
|---|---|
| Strong Buy | 1 |
| Buy | 0 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +249.34% | Dec 3, 2025 |
Financial Forecast
Revenue This Year
234.60K
from 226.00K
Increased by 3.81%
Revenue Next Year
306.00K
from 234.60K
Increased by 30.43%
EPS This Year
-36.23
from -35.21
EPS Next Year
-0.83
from -36.23
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 241,500 | 315,000 |
| Avg | 234,600 | 306,000 |
| Low | 225,400 | 294,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 6.9% | 34.3% |
| Avg | 3.8% | 30.4% |
| Low | -0.3% | 25.3% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -37.30 | -0.85 |
| Avg | -36.23 | -0.83 |
| Low | -34.81 | -0.79 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.